ORMP

Oramed Pharmaceuticals Inc

ORMP.US oramed.com
4.66
-0.10 (-2.10%)
USD · NASDAQ
52-week range
1.95
5.47
Trading at 77% of the 52-week range
Market Cap
193.84M
P/E Ratio
1.13
Forward P/E
0.00
Book Value
7.68
Div. Yield
0.00%
% Institutions
45.11%
% Insiders
17.65%

1 Year

+105.7%

3 Year

+63.4%

10 Year

-32.6%
Description

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York.

Company Information

Company Name
Oramed Pharmaceuticals Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US68403P2039
CIK: 0001176309
CUSIP: 68403P104
Currency: USD
Full Time Employees: 0
Phone: 844 967 2633
Website: oramed.com
Fiscal Year End: December
IPO Date: Apr 21, 2006
Description:

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York.

Address:

1185 Avenue of the Americas, New York, NY, United States, 10036

People

Directors & Officers

Name Title Year Born
Mr. Nadav Kidron Esq. President, CEO & Executive Chairman 1974
Mr. Joshua Hexter Chief Operating & Business Officer 1970
Dr. Miriam Kidron Ph.D. Chief Scientific Officer & Director 1940
Mr. Avraham Gabay CFO, Treasurer & Secretary 1985

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Jan 10, 2025 Brad Knott N/A Sale N/A $2.39 N/A
Mar 16, 2023 Nadav Kidron N/A Purchase 26.00K $2.04 $53.04K

Shareholders

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Aquamarine Financial (Cayman) Ltd 2.51M Jun 30, 2026 6.04% $0.67 18.93%
Gem Investment Advisors, LLC 2.00M Jun 30, 2026 4.81% $5.89 21.87%
Mercer Global Advisors Inc. 1.91M Jun 30, 2026 4.59% $0.01 0.00%
Murchinson Ltd. 1.32M Mar 31, 2026 3.16% $0.57 -1.86%
BML Capital Management LLC 866.27K Jun 30, 2026 2.08% $2.37 -72.65%
BOOTHBAY FUND MANAGEMENT, LLC 600.72K Mar 31, 2026 1.44% $0.03 -1.87%
Marshall Wace Asset Management Ltd 259.61K Mar 31, 2026 0.62% $0.00 0.21%
Rathbone Brothers PLC 233.02K Jun 30, 2026 0.56% $0.00 -50.00%
Dimensional Fund Advisors, Inc. 202.61K Jun 30, 2026 0.49% $0.00 28.06%
Wells Fargo & Co 157.59K Mar 31, 2026 0.38% $0.00 20.68%
Renaissance Technologies Corp 147.70K Mar 31, 2026 0.36% $0.00 0.14%
Bank of America Corp 146.15K Mar 31, 2026 0.35% $0.00 2.75%
Susquehanna International Group, LLP 136.22K Mar 31, 2026 0.33% $0.00 424.24%
O'Shaughnessy Asset Management LLC 116.36K Mar 31, 2026 0.28% $0.00 0.00%
BlackRock Inc 92.19K Mar 31, 2026 0.22% $0.00 2.19%
Hillsdale Investment Management Inc. 89.30K Jun 30, 2026 0.21% $0.01 -8.22%
Comprehensive Portfolio Management, LLC 84.35K Jun 30, 2026 0.20% $0.01 -45.75%
American Century Companies Inc 59.78K Jun 30, 2026 0.14% $0.00 85.02%
Jane Street Group LLC 52.54K Mar 31, 2026 0.13% $0.00 -32.86%
Connor Clark & Lunn Inv Mgmt Ltd 50.21K Mar 31, 2026 0.12% $0.00 14.80%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 iShares Russell 2000 ETF 625.04K 1.50% ▼ 0.57% Aug 31, 2026
2 Fidelity Small Cap Index 376.45K 0.91% ▲ 0.00% Jun 30, 2026
3 iShares Russell 2000 Value ETF 315.20K 0.76% ▼ 0.23% Aug 31, 2026
4 Russell 2000 Equity Index Fund B 204.87K 0.49% ▲ 0.00% Jun 30, 2026
5 Russell 2000 Index Non-Lendable Fund 204.87K 0.49% ▲ 0.00% Jun 30, 2026
6 Vanguard Russell 2000 ETF 190.62K 0.46% ▼ 3.12% Jul 31, 2026
7 State St Russell Sm Cap® Idx SL Cl I 126.50K 0.30% ▲ 0.00% Aug 31, 2026
8 iShares Micro-Cap ETF 117.34K 0.28% ▼ 1.95% Aug 31, 2026
9 Schwab Small Cap Index 83.63K 0.20% ▲ 0.00% Jul 31, 2026
10 NT R2000 Index Fund - NL 77.32K 0.19% ▲ 0.00% Jun 30, 2026

Financial Highlights

Market Cap: $193.84M
EBITDA: $-14.40M
P/E Ratio: $1.13
PEG Ratio: $0.00
Book Value: $7.68
Dividend/Share: $0.00
Dividend Yield: 0.00%
Earnings/Share: $4.13
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -3.42%
ROE (TTM): 74.24%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 493.50%
Revenue Growth (YOY): -100.00%

Valuation Metrics

Enterprise Value: $143.96M
Trailing P/E: 1.13
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 41.60M
Shares Float: 31.77M
% Insiders: 17.65%
% Institutions: 45.11%
Short % Float: 3.27%

Stock Price History

1 Year Price History

3 Years Price History

10 Years Price History

Financial Charts

Revenue, Net Income & Operating Cash Flow (Yearly)

Revenue, Net Income & Operating Cash Flow (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$2.00M
Cost of Goods Sold
adjust
$-1.99M
Gross Profit
subtotal
$13.00K
SG&A
adjust
$-8.72M
R&D
adjust
$-6.38M
Operating Income
subtotal
$-15.09M
Other / Non-Operating Items
adjust
$79.14M
Net Income
subtotal
$64.05M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about ORMP.US!